Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABIGATRAN ETEXILATE Cause Back pain? 222 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 222 reports of Back pain have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.6% of all adverse event reports for DABIGATRAN ETEXILATE.

222
Reports of Back pain with DABIGATRAN ETEXILATE
0.6%
of all DABIGATRAN ETEXILATE reports
7
Deaths
88
Hospitalizations

How Dangerous Is Back pain From DABIGATRAN ETEXILATE?

Of the 222 reports, 7 (3.2%) resulted in death, 88 (39.6%) required hospitalization, and 5 (2.3%) were considered life-threatening.

Is Back pain Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 222 reports have been filed with the FAERS database.

What Other Side Effects Does DABIGATRAN ETEXILATE Cause?

Gastrointestinal haemorrhage (4,081) Cerebrovascular accident (2,175) Fall (1,786) Ischaemic stroke (1,581) Anaemia (1,412) Haemorrhage (1,324) Death (1,025) Rectal haemorrhage (964) Cerebral haemorrhage (946) Upper gastrointestinal haemorrhage (861)

What Other Drugs Cause Back pain?

ADALIMUMAB (9,779) ETANERCEPT (6,029) EVOLOCUMAB (5,254) METHOTREXATE (4,580) LENALIDOMIDE (4,531) DENOSUMAB (4,465) SECUKINUMAB (4,161) TERIPARATIDE (3,929) TOFACITINIB (3,213) RITUXIMAB (2,637)

Which DABIGATRAN ETEXILATE Alternatives Have Lower Back pain Risk?

DABIGATRAN ETEXILATE vs DABRAFENIB DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB DABIGATRAN ETEXILATE vs DACARBAZINE DABIGATRAN ETEXILATE vs DACLATASVIR DABIGATRAN ETEXILATE vs DACLIZUMAB

Related Pages

DABIGATRAN ETEXILATE Full Profile All Back pain Reports All Drugs Causing Back pain DABIGATRAN ETEXILATE Demographics